ERBB2 and neoplasm: For example, TET1 expression and 5hmC levels are decreased in tumor samples from luminal A, luminal B, and HER2-positive subtypes compared to normal breast tissue samples and correlate with larger tumors, advanced stage, lymph node status, and poor patient survival74–77.